Role of homeobox d10 gene targeted signaling pathways in cancers.Homeobox D10 (HOXD10) is a transcription factor from the homeobox gene family that controls cell differentiation and morphogenesis throughout development.Due to their functional interaction, changes in HOXD10 gene expression might induce tumors.  This narrative review focuses on how and why the dysregulation in the signaling pathways linked with HOXD10 contributes to the metastatic development of cancer.  The HOXD10 gene is upregulated in breast, gastric, hepatocellular, colorectal, bladder, cholangiocellular carcinoma and prostate cancer.  Tumor signaling pathways are affected by HOXD10 gene expression changes.  This study examines HOXD10-associated signaling pathway dysregulation, which may alter metastatic cancer signaling.  In addition, the theoretical foundations that alter HOXD10-mediated therapeutic resistance in malignancies has been presented.  This review showed that HOXD10 may be a tumor suppressor gene and a new cancer treatment target signaling pathway.
HOXD10
Role of homeobox d10 gene targeted signaling pathways in cancers.Homeobox D10 (HOXD10) is a transcription factor from the homeobox gene family that controls cell differentiation and morphogenesis throughout development.Due to their functional interaction, changes in HOXD10 gene expression might induce tumors.  This narrative review focuses on how and why the dysregulation in the signaling pathways linked with HOXD10 contributes to the metastatic development of cancer.  The HOXD10 gene is upregulated in breast, gastric, hepatocellular, colorectal, bladder, cholangiocellular carcinoma and prostate cancer.  Tumor signaling pathways are affected by HOXD10 gene expression changes.  This study examines HOXD10-associated signaling pathway dysregulation, which may alter metastatic cancer signaling.  In addition, the theoretical foundations that alter HOXD10-mediated therapeutic resistance in malignancies has been presented.  This review showed that HOXD10 may be a tumor suppressor gene and a new cancer treatment target signaling pathway.
HOXD10
Role of homeobox d10 gene targeted signaling pathways in cancers.Homeobox D10 (HOXD10) is a transcription factor from the homeobox gene family that controls cell differentiation and morphogenesis throughout development.Due to their functional interaction, changes in HOXD10 gene expression might induce tumors.  This narrative review focuses on how and why the dysregulation in the signaling pathways linked with HOXD10 contributes to the metastatic development of cancer.  The HOXD10 gene is upregulated in breast, gastric, hepatocellular, colorectal, bladder, cholangiocellular carcinoma and prostate cancer.  Tumor signaling pathways are affected by HOXD10 gene expression changes.  This study examines HOXD10-associated signaling pathway dysregulation, which may alter metastatic cancer signaling.  In addition, the theoretical foundations that alter HOXD10-mediated therapeutic resistance in malignancies has been presented.  This review showed that HOXD10 may be a tumor suppressor gene and a new cancer treatment target signaling pathway.
HOXD10
Role of homeobox d10 gene targeted signaling pathways in cancers.Homeobox D10 (HOXD10) is a transcription factor from the homeobox gene family that controls cell differentiation and morphogenesis throughout development.Due to their functional interaction, changes in HOXD10 gene expression might induce tumors.  This narrative review focuses on how and why the dysregulation in the signaling pathways linked with HOXD10 contributes to the metastatic development of cancer.  The HOXD10 gene is upregulated in breast, gastric, hepatocellular, colorectal, bladder, cholangiocellular carcinoma and prostate cancer.  Tumor signaling pathways are affected by HOXD10 gene expression changes.  This study examines HOXD10-associated signaling pathway dysregulation, which may alter metastatic cancer signaling.  In addition, the theoretical foundations that alter HOXD10-mediated therapeutic resistance in malignancies has been presented.  This review showed that HOXD10 may be a tumor suppressor gene and a new cancer treatment target signaling pathway.
HOXD10